SE384206B - Sett att framstella nya 2-amino-4,5-dihydropyridin-3,5-dikarbonsyraestrar - Google Patents

Sett att framstella nya 2-amino-4,5-dihydropyridin-3,5-dikarbonsyraestrar

Info

Publication number
SE384206B
SE384206B SE7303018A SE7303018A SE384206B SE 384206 B SE384206 B SE 384206B SE 7303018 A SE7303018 A SE 7303018A SE 7303018 A SE7303018 A SE 7303018A SE 384206 B SE384206 B SE 384206B
Authority
SE
Sweden
Prior art keywords
dihydropyridine
amino
methods
acid esters
producing new
Prior art date
Application number
SE7303018A
Other languages
English (en)
Swedish (sv)
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2210650A external-priority patent/DE2210650C3/de
Priority claimed from DE19722260860 external-priority patent/DE2260860A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE384206B publication Critical patent/SE384206B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7303018A 1972-03-06 1973-03-05 Sett att framstella nya 2-amino-4,5-dihydropyridin-3,5-dikarbonsyraestrar SE384206B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2210650A DE2210650C3 (de) 1972-03-06 1972-03-06 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19722260860 DE2260860A1 (de) 1972-12-13 1972-12-13 Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva

Publications (1)

Publication Number Publication Date
SE384206B true SE384206B (sv) 1976-04-26

Family

ID=25762843

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7303018A SE384206B (sv) 1972-03-06 1973-03-05 Sett att framstella nya 2-amino-4,5-dihydropyridin-3,5-dikarbonsyraestrar

Country Status (16)

Country Link
US (1) US3876646A (fr)
JP (1) JPS5626658B2 (fr)
AT (1) AT325614B (fr)
CA (1) CA985685A (fr)
CH (1) CH580591A5 (fr)
CS (1) CS179980B2 (fr)
DD (1) DD106832A5 (fr)
DK (1) DK135714C (fr)
ES (1) ES412320A1 (fr)
FR (1) FR2183673B1 (fr)
GB (1) GB1374551A (fr)
HU (1) HU167088B (fr)
IE (1) IE37367B1 (fr)
IL (1) IL41666A (fr)
NL (1) NL7303134A (fr)
SE (1) SE384206B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
IE37367L (en) 1973-09-06
CA985685A (en) 1976-03-16
CH580591A5 (fr) 1976-10-15
IL41666A (en) 1976-02-29
JPS4899180A (fr) 1973-12-15
DK135714B (da) 1977-06-13
DK135714C (da) 1977-11-14
AT325614B (de) 1975-10-27
FR2183673A1 (fr) 1973-12-21
DD106832A5 (fr) 1974-07-05
NL7303134A (fr) 1973-09-10
HU167088B (fr) 1975-08-28
JPS5626658B2 (fr) 1981-06-19
US3876646A (en) 1975-04-08
GB1374551A (en) 1974-11-20
FR2183673B1 (fr) 1976-12-03
CS179980B2 (en) 1977-12-30
IL41666A0 (en) 1973-05-31
ATA196973A (de) 1975-01-15
ES412320A1 (es) 1976-04-16
IE37367B1 (en) 1977-07-06

Similar Documents

Publication Publication Date Title
SE398876B (sv) Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar
SE407577B (sv) Sett att framstella metallsalter av dialkyltiofosforsyra
IT990346B (it) Procedimento per la produzione di acido acrilico
DK139302B (da) Fremgangsmåde til fremstilling af 6-aminopenicillansyre.
IT995276B (it) Procedimento per la produzione di fullulano
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
IT997911B (it) Procedimento per la produzione di etilbenzolo
SE382457B (sv) Forfarande for framstellning av bensopyrankarbonsyror.
SE389673B (sv) Sett att framstella nya estrar av 2-alkyltiazol-5-karbonsyra
SE401177B (sv) Sett att framstella nya basiskt substituerade alkylidenamino-oxialkylkarboxylsyraestrar
IT965273B (it) Procedimento per la produzione di esteri alcossiacetacetici
SE385883B (sv) Forfarande for framstellning av nya pyridinkarbonsyraestrar
IT1029578B (it) Procedimento per la produzione pirazoli sostituite
DK132273B (da) Fremgangsmåde til fremstilling af trans-chrysanthemsyre.
DK139778B (da) Fremgangsmåde til fremstilling af 6-aminopenicillansyre.
SE409458B (sv) Sett att framstella 7-amino-desacetoxi-cefalosporansyra
SE385303B (sv) Sett att framstella 1-imidazolyl-metanfosfonsyraestrar
SE384206B (sv) Sett att framstella nya 2-amino-4,5-dihydropyridin-3,5-dikarbonsyraestrar
IT954173B (it) Procedimento per la produzione di acido tetronico
IT1002879B (it) Procedimento per la produzione di perfluoroalcansolfonammidi terzia rie
IT979907B (it) Procedimento per la produzione di diesteri di acido succinilsuccinico
IT997528B (it) Procedimento per produrre acido acrilico
IT995292B (it) Procedimento per la produzione di lattame
IT996245B (it) Procedimento per la produzione di amminoantrachinoni
SE402286B (sv) Forfarande for framstellning av substituerade isokinoliner